These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatic iron clearance from serum in treated hemochromatosis. Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of hemochromatosis]. Stremmel W; Niederau C; Strohmeyer G Dtsch Med Wochenschr; 1988 Oct; 113(42):1648-50. PubMed ID: 3181017 [No Abstract] [Full Text] [Related]
9. [Diagnosis of primary hemochromatosis]. Niederau C; Stremmel W; Strohmeyer G Dtsch Med Wochenschr; 1988 Oct; 113(42):1644-7. PubMed ID: 3181016 [No Abstract] [Full Text] [Related]
10. Hypogonadal-induced anemia in genetic hemochromatosis: implications for phlebotomy therapy. Sigal SH; Fleischner GM; Weiner FR Am J Gastroenterol; 1995 Jan; 90(1):152-3. PubMed ID: 7801923 [No Abstract] [Full Text] [Related]
11. Idiopathic hemochromatosis: serum ferritin concentrations during therapy by phlebotomy. Garry PJ; Saiki JH Clin Chem; 1982 Aug; 28(8):1806-8. PubMed ID: 7094303 [TBL] [Abstract][Full Text] [Related]
12. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Aruoma OI; Bomford A; Polson RJ; Halliwell B Blood; 1988 Oct; 72(4):1416-9. PubMed ID: 2458783 [TBL] [Abstract][Full Text] [Related]
13. Advances in the use of iron-chelating agents for the treatment of iron overload. Modell B Prog Hematol; 1979; 11():267-312. PubMed ID: 392593 [No Abstract] [Full Text] [Related]